Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sacubitril/Valsartan for Dialysis Patients With CKD5 Stage Complicated With Hypertension- A Prospective, Randomized, Controlled Multicenter Study

NCT05243199 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT05243199
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05243199 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sacubitril/Valsartan for Dialysis Patients With CKD5 Stage Complicated With Hypertension- A Prospective, Randomized, Controlled Multicenter Study
Lead sponsor
Ruijin Hospital
Phase
Phase 4
Overall status
Completed
Start date
August 1, 2020
Completion date
March 8, 2023
Enrollment
330 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ckd5 stage dialysis, heart failure